Correlation Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Pathological Subtypes of Invasive Lung Adenocarcinoma …

B Yang, H Ji, Y Ge, S Chen, H Zhu, G Lu - Frontiers in Oncology, 2019 - frontiersin.org
… use PET/CT metabolic parameters and clinicopathological factors to study the correlation
between the pathological subtypes of invasive lung adenocarcinoma … The differences in largest …

18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma

M Nishimori, H Iwasa, K Miyatake, N Nitta… - Annals of Nuclear …, 2022 - Springer
… On the other hand, there was no significant difference between the presence of STAS and
PET parameters among solid nodule lesions. Compared with part-solid nodules, the influence …

[HTML][HTML] … of 18f-fluorodeoxyglucose pet/ct radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung adenocarcinoma

S Li, Y Li, M Zhao, P Wang, J Xin - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
… Although there was no statistical difference in the AUROCs between the combined and
PET/CT radiomics model in both the training and testing cohorts (0.853 vs. 0.882, p = 0.145; …

Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT

P Heusch, C Buchbender, J Köhler… - Journal of Nuclear …, 2014 - Soc Nuclear Med
… For thoracic lymph node metastases detection, we did not find a statistically significant
difference for 18 F-FDG PET/MR imaging and 18 F-FDG PET/CT. For definition of thoracic N …

TNM staging of non–small cell lung cancer: comparison of PET/MR and PET/CT

MW Huellner, F de Galiza Barbosa… - Journal of nuclear …, 2016 - Soc Nuclear Med
… Like them, we found no significant difference in the N staging with both … of PET/CT plus brain
MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma. …

[HTML][HTML] … tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma

M Okada, H Nakayama, S Okumura, H Daisaki… - The Journal of Thoracic …, 2011 - Elsevier
… We also found significant differences in DFS between patients whose … -PET/CT is a potentially
promising parameter of the degree of malignancy among cT1N0M0 lung adenocarcinoma.…

Relationship between primary lesion FDG uptake and clinical stage at PET–CT for non-small cell lung cancer patients: An observation

M Li, Y Sun, Y Liu, A Han, S Zhao, L Ma, J Zheng, J Yu - Lung Cancer, 2010 - Elsevier
… international staging system for lung cancer. From December … Significant difference is found
among different stages in … with tumor stage in lung adenocarcinoma patients. For squamous …

FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation

SS Shim, J Han - Annals of nuclear medicine, 2010 - Springer
… mBACs were lower than the other types of mucin-producing adenocarcinoma; however, we
determined no significant difference to exist between the SUVs of two groups of lung cancer. …

Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 …

N Suzawa, M Ito, S Qiao, K Uchida, M Takao… - Lung Cancer, 2011 - Elsevier
… An important advantage of PET/CT is that it enables … using PET/CT imaging by comparing
histological differences in the … Therefore, we adopted the term ‘adenocarcinoma (AC) in situ…

Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma

A Carretta, A Bandiera, P Muriana, S Viscardi… - Radiology and …, 2020 - sciendo.com
… The aim of the study was to assess the role of CT and PET parameters in stratifying patients
… Univariate analysis showed a significant difference in SUVmax, SUVindex, GGO ratio and …